Table: begin end state 1 26 cytoplasmic 27 45 transmembrane 46 62 non-cytoplasmic 63 85 transmembrane 86 96 cytoplasmic 97 117 transmembrane 118 122 non-cytoplasmic 123 146 transmembrane 147 159 cytoplasmic 160 185 transmembrane 186 190 non-cytoplasmic 191 210 transmembrane 211 259 cytoplasmic 260 278 transmembrane 279 297 non-cytoplasmic 298 318 transmembrane 319 326 cytoplasmic 327 345 transmembrane 346 351 non-cytoplasmic 352 379 transmembrane 380 391 cytoplasmic 392 411 transmembrane 412 422 non-cytoplasmic 423 446 transmembrane 447 463 cytoplasmic
Input: >BWI76_RS27785 FitnessBrowser__Koxy:BWI76_RS27785 MLAFLNQVRKPTLDLPLEARRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTY GLSMTQLGMIGLGFSITYGVGKTLVSYYADGKNTKQFLPFMLILSAICMLGFSASMGAGS TSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGTFLGFWNISHNLGGAGAAGVAL FGANYLFDGHVIGMFIFPSIIALIVGFIGLRFGSDSPESYGLGNAEELFGEEISEEDKET EENAMTKWQIFVEYVLKNKVIWLLCFSNIFLYVVRIGIDQWSTVYAFQELKLSKEVAIQG FTLFEVGALVGTLLWGWLSDLANGRRALVACVALALIIATLGVYQHASNQYVYLASLFAL GFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPIFGLT GWAGTFAALDAAAIGCICLMAIVAVFEERKIRRQKKTQTLQTA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server